WO2010140832A2 - 생약 추출물을 함유하는 신장염 질환 예방 또는 치료용 약학 조성물 - Google Patents

생약 추출물을 함유하는 신장염 질환 예방 또는 치료용 약학 조성물 Download PDF

Info

Publication number
WO2010140832A2
WO2010140832A2 PCT/KR2010/003530 KR2010003530W WO2010140832A2 WO 2010140832 A2 WO2010140832 A2 WO 2010140832A2 KR 2010003530 W KR2010003530 W KR 2010003530W WO 2010140832 A2 WO2010140832 A2 WO 2010140832A2
Authority
WO
WIPO (PCT)
Prior art keywords
herbal extracts
preventing
treating nephritis
pharmaceutical composition
nephritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/003530
Other languages
English (en)
French (fr)
Other versions
WO2010140832A3 (ko
Inventor
어진
김창환
한창균
연성흠
최승인
신영준
한동오
장수임
이지혜
이준석
곽호영
문효진
이종욱
김성민
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ahn Gook Pharmaceutical Co Ltd
Original Assignee
Ahn Gook Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020090049626A external-priority patent/KR101088299B1/ko
Application filed by Ahn Gook Pharmaceutical Co Ltd filed Critical Ahn Gook Pharmaceutical Co Ltd
Priority to US13/375,255 priority Critical patent/US8642096B2/en
Priority to BRPI1014046A priority patent/BRPI1014046A2/pt
Priority to CN201080034444.7A priority patent/CN102497874B/zh
Priority to EP10783581.1A priority patent/EP2438924B1/en
Publication of WO2010140832A2 publication Critical patent/WO2010140832A2/ko
Publication of WO2010140832A3 publication Critical patent/WO2010140832A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

생약 추출물의 신장염 질환 예방 또는 치료용 약학 조성물에 있어서의 신규한 용도에 관한 것으로서, 더욱 상세하게는 서양산사, 육계, 하고초 및 목적으로 이루어진 군에서 선택된 1종 이상의 생약 추출물을 함유하는 신장염 질환 예방 및/또는 치료용 약학 조성물, 및 건강기능식품, 상기 생약 추출물을 사용하는 신장염 치료 방법, 및 상기 생약 추출물의 신장염 예방 및/또는 치료용 조성물 제조에 있어서의 용도가 제공된다. 상기 생약 추출물은 겐타마이신, 시스플라틴 등의 약물 유발 신장염 모델에 대한 신장염 치료 효과와 신장 메산기움 세포(Mesangial Cell)에 대한 세포 성장 억제 활성이 우수하여 신장염 질환 예방 및/또는 치료에 매우 유용하다.
PCT/KR2010/003530 2009-06-04 2010-06-01 생약 추출물을 함유하는 신장염 질환 예방 또는 치료용 약학 조성물 Ceased WO2010140832A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/375,255 US8642096B2 (en) 2009-06-04 2010-06-01 Pharmaceutical composition containing herbal extract for prevention or treatment of nephritis
BRPI1014046A BRPI1014046A2 (pt) 2009-06-04 2010-06-01 composição, alimento funcional para a saúde, uso de pelo menos um extrato e método para a prevenção ou tratamento da nefrite.
CN201080034444.7A CN102497874B (zh) 2009-06-04 2010-06-01 用于预防或治疗肾炎的含有药草提取物的药物组合物
EP10783581.1A EP2438924B1 (en) 2009-06-04 2010-06-01 Pharmaceutical composition containing herbal extracts for preventing or treating nephritis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090049626A KR101088299B1 (ko) 2008-11-26 2009-06-04 생약 추출물을 함유하는 신장염 질환 예방 및 치료용 약학 조성물
KR10-2009-0049626 2009-06-04

Publications (2)

Publication Number Publication Date
WO2010140832A2 true WO2010140832A2 (ko) 2010-12-09
WO2010140832A3 WO2010140832A3 (ko) 2011-04-14

Family

ID=43298881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/003530 Ceased WO2010140832A2 (ko) 2009-06-04 2010-06-01 생약 추출물을 함유하는 신장염 질환 예방 또는 치료용 약학 조성물

Country Status (5)

Country Link
US (1) US8642096B2 (ko)
EP (1) EP2438924B1 (ko)
CN (1) CN102497874B (ko)
BR (1) BRPI1014046A2 (ko)
WO (1) WO2010140832A2 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641379A (zh) * 2012-05-09 2012-08-22 甘肃陇神戎发药业股份有限公司 一种七味温阳软胶囊制剂及其制备工艺

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102813116A (zh) * 2012-09-07 2012-12-12 廖衍庆 保健食品
CN109999087B (zh) * 2018-01-05 2021-10-19 鼎赫生物科技股份有限公司 一种具有抑制α-葡萄糖苷酶活性的天然组合物用于调控血糖及醣类的吸收
CN113880959B (zh) * 2021-09-07 2023-03-14 黑龙江中医药大学 一种黄精均一多糖及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060030535A (ko) 2004-10-06 2006-04-11 학교법인 경희대학교 항불안 활성을 갖는 육계 추출물을 함유하는 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159673A (ja) 1998-11-27 2000-06-13 Taisho Pharmaceut Co Ltd 形質転換増殖因子β阻害剤
KR19990014646A (ko) * 1998-11-30 1999-02-25 서희영 정혈, 소염을 위한 냉동 녹즙
KR20010018668A (ko) * 1999-08-20 2001-03-15 유상옥 육계피 추출물을 함유하는 화장료 조성물
US6399116B1 (en) * 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof
KR100336649B1 (ko) * 2000-12-26 2002-05-16 강창환 장 청소 및 변비 해소 기능의 야채 효소 음료 조성물
KR100496622B1 (ko) * 2002-04-29 2005-06-29 (주) 김형민한약연구소 비만 억제를 위한 알콜 발효 식품 또는 약학적 조성물 및그의 제조방법
KR20040058526A (ko) 2002-12-27 2004-07-05 주식회사 하이닉스반도체 미세전자기계시스템(ｍｅｍｓ) 구조체를 이용한 반도체장치의 입출력 셀
KR100516194B1 (ko) * 2002-12-27 2005-09-21 김성호 항종양활성을 갖는 생약 추출물
KR20030029563A (ko) * 2003-03-11 2003-04-14 김대곤 함초,석창포 를 주제로 한 건강식품
US20040258740A1 (en) 2003-04-10 2004-12-23 Nene Labs Transdermal delivery composition
CN100382819C (zh) * 2003-06-12 2008-04-23 曾广财 一种治疗肾炎的胶囊
EP2015645A2 (en) * 2006-03-23 2009-01-21 Herbalscience Singapore Pte. Ltd. Extracts and methods comprising cinnamon species
US8153166B2 (en) * 2006-06-08 2012-04-10 Chih-Hsiung Lin Composition for prophylaxis or treatment of urinary system infection and method thereof
CN100518807C (zh) 2006-10-23 2009-07-29 龙敦成 一种治疗肝硬化腹水的药物
CN101167802B (zh) * 2006-10-25 2011-04-20 中国科学院上海生命科学研究院 肉桂提取物的制备方法、肉桂提取物、其组合物以及用途
US7498048B2 (en) * 2006-11-16 2009-03-03 Jose Angel Olalde Rangel Renal phyto-nutraceutical composition
CN101530469B (zh) * 2009-04-20 2011-10-05 孙益民 一种水溶性肉桂有效成分群制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060030535A (ko) 2004-10-06 2006-04-11 학교법인 경희대학교 항불안 활성을 갖는 육계 추출물을 함유하는 조성물

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AMIN ET AL., ENVIRONMENTAL HEALTH PERSPECTIVES, vol. 112, no. 4, March 2004 (2004-03-01), pages 465 - 479
HEE KEE KIM ET AL., ARCH. PHARM. RES., vol. 16, no. 1, 1993, pages 18 - 24
R. WANG ET AL., LIFE SCIENCES, vol. 80, 2007, pages 2481 - 2488
See also references of EP2438924A4
SHIRWAIKAR ET AL., JOURNAL OF ETHNOPHARMACOLOGY, vol. 90, 2004, pages 81 - 86
YOUNG LEE ET AL., EXPERIMENTAL TRANSPLANTATION, vol. 78, 2004, pages 1756 - 1764

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641379A (zh) * 2012-05-09 2012-08-22 甘肃陇神戎发药业股份有限公司 一种七味温阳软胶囊制剂及其制备工艺
CN102641379B (zh) * 2012-05-09 2013-11-06 甘肃陇神戎发药业股份有限公司 一种七味温阳软胶囊制剂及其制备工艺

Also Published As

Publication number Publication date
CN102497874A (zh) 2012-06-13
US20120070517A1 (en) 2012-03-22
BRPI1014046A2 (pt) 2016-04-12
US8642096B2 (en) 2014-02-04
EP2438924A4 (en) 2013-10-30
EP2438924A2 (en) 2012-04-11
WO2010140832A3 (ko) 2011-04-14
CN102497874B (zh) 2014-07-30
EP2438924B1 (en) 2017-02-22

Similar Documents

Publication Publication Date Title
WO2007098127A3 (en) Compositions for treating wounds and processes for their preparation
SG170751A1 (en) Extractions and methods comprising elder species
ZA200908761B (en) Crystalline solid IZM-2 and method for the preparation thereof
WO2007005912A3 (en) Compositions for treating wounds and processes for their preparation
HK1258915A1 (zh) 芳基-2-噁唑氰乙基氨基化合物、其製造方法及用法
CL2007003765A1 (es) Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias.
ZA201003221B (en) Tea composition and process for the manufacture thereof
MX2010003726A (es) Composiciones herbarias y metodos de tratamiento de trastornos hepaticos.
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
WO2010005565A3 (en) Method of treating glycogen storage disease
WO2010140832A3 (ko) 생약 추출물을 함유하는 신장염 질환 예방 또는 치료용 약학 조성물
BRPI0919298A2 (pt) composição para a prevenção ou o tratamento da aids que compreende a linhagem de células do tronco da planta derivada do câmbio da panax ginseng incluindo ginseng selvagem ou ginseng como ingrediente ativo.
WO2007100765A3 (en) Lysozyme-modified probiotic components and uses thereof
TW200705128A (en) Remover compositions
WO2006105538A3 (en) Methods and compositions for treating il-21 related pathologies
WO2006078699A3 (en) Oral care compositions derived from the labiatae family
WO2007065023A3 (en) Processes for obtaining lignan extracts and compositions containing the lignan extracts
WO2009061950A3 (en) Endophytic fungi from pteromischum sp. plant, compounds and methods of use
EP2003988A4 (en) COMPOSITION BASED ON NATURAL PLANT EXTRACTS FOR THE PREVENTION AND TREATMENT OF HYPERLIPIDEMIA AND THE CEREBROVASCULAR ACCIDENT, NATURAL TEA CONTAINING THE ACTIVE INGREDIENT AND PROCESS FOR THE PREPARATION OF NATURAL TEA
GEP20115332B (en) Herbal composition for inflammatory disorders
TW200718427A (en) Composition for treating cancer cells and preparation method thereof
WO2007079119A3 (en) Process for manufacturing picolinate borinic esters
PL1966099T3 (pl) Kompozycja, fryta, emalia oraz ceramiczne komponenty i proces w celu ich uzyskania
WO2012123962A3 (en) A novel herbal composition for the treatment of wound healing, a regenerative medicine
TW200726763A (en) Novel compound

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080034444.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10783581

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13375255

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2010783581

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010783581

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI1014046

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI1014046

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20111130